Pharmacology

Action Mechanism of Action Reference
HYDROLYTIC ENZYME DNA hydrolytic enzyme DailyMed

Indications

Mesh Heading Maximum Phase Mesh ID Reference
Respiratory Distress Syndrome 3 D012128 ClinicalTrials
Empyema 3 D004653 ClinicalTrials
Sinusitis 3 D012852 ClinicalTrials
Wounds and Injuries 3 D014947 ClinicalTrials
Empyema, Pleural 3 D016724 ClinicalTrials
Respiratory Distress Syndrome 3 D012128 ClinicalTrials
Severe Acute Respiratory Syndrome 3 D045169 ClinicalTrials
Severe Acute Respiratory Syndrome 3 D045169 ClinicalTrials
Asthma 2 D001249 ClinicalTrials
Infections 2 D007239 ClinicalTrials
Ischemic Stroke 2 D000083242 ClinicalTrials
Hypoxia 2 D000860 ClinicalTrials
Cough 1 D003371 ClinicalTrials
Pleural Effusion 1 D010996 ClinicalTrials
Dry Eye Syndromes 1 D015352 ClinicalTrials
Sjogren's Syndrome 1 D012859 ClinicalTrials
Graft vs Host Disease 1 D006086 ClinicalTrials
Head and Neck Neoplasms 0 D006258 ClinicalTrials

Adverse Reactions

System Organ Classification (SOC)
Relative Frequency (%)
Respiratory, thoracic and mediastinal disorders
22.29
General disorders and administration site conditions
19.19
Injury, poisoning and procedural complications
15.08
Infections and infestations
10.1
Gastrointestinal disorders
5.75
Cardiac disorders
4.68
Vascular disorders
3.16
Investigations
3.01
Metabolism and nutrition disorders
2.77
Nervous system disorders
2.53
Congenital, familial and genetic disorders
2.15

Cross References

Resources Reference
CAS NUMBER 143831-71-4
ChEMBL CHEMBL1201431
FDA SRS 953A26OA1Y